Status:
COMPLETED
Evaluation of a Health Dashboard Intervention to Improve Engagement With CPAP Therapy in PAP-Naïve Patients: Project Neo
Lead Sponsor:
ResMed
Conditions:
Sleep Apnea, Obstructive
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective, open-label study to evaluate the effectiveness of providing a dashboard with merged health metrics of CPAP (continuous positive airway pressure/ PAP) usage, self-reported sleepi...
Eligibility Criteria
Inclusion
- Participant is at least 18 years old.
- Participant is using a ResMed AirSense 10 device and ResMed myAir mobile app.
- Participant has been using CPAP therapy for less than 2 weeks.
- Participant has been enrolled in myAir for less than 2 weeks.
- Participants have self-reported resistant hypertension and they take 3 or more drugs to treat their hypertension.
- Participant owns a mobile device compatible with the Neo app (Android Jelly Bean, v16, 4.1.x or newer, and iOS 8 or newer)
- Participant is somewhat to fairly confident about being able to use Bluetooth connected devices and apps
- Participant consents to download the Neo app, Withings app, create a Withings account, and sync Withings data to ResMed's Project Neo.
- Willing and able to give informed consent
- Can read and comprehend written and spoken English
Exclusion
- Are participating in another app-based research study
- Cannot participate for the full duration of the study (at least 45 days)
- Unable to read or write English
- Participant is pregnant
- Participant is on Medicare
Key Trial Info
Start Date :
September 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 25 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04912635
Start Date
September 25 2020
End Date
March 25 2021
Last Update
June 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ResMed
Bella Vista, New South Wales, Australia, 2153